When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
TCRR - TCR² Therapeutics to announce interim data from its lead drug's early-stage study
TCR2 Therapeutics Inc.
TCR2 Therapeutics (NASDAQ:TCRR) up 7.6% AH, in reaction to company's plans to discuss initial data from the Phase 1 portion of Phase 1/2 trial of its lead drug TC-210, in patients with mesothelin-expressing solid tumors, on Monday.
More news on: TCR2 Therapeutics Inc., Healthcare stocks news, Stocks on the move,